Effects of Zinc Supplementation on Improving Immune Function in Patients with Sepsis

Phase 1

• Conditions: Sepsis

• Registration Number: JPRN-jRCTs051220200
• Lead Sponsor: Inoue Shigeaki

Brief Summary

ot applicable due to lack of cases performed.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-03-23
• Study Completion: 2023-09-30
• Last Update Posted: 20 November 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 0

Inclusion Criteria

1) Age 18 years or older at the time consent is obtained.
2) Any gender.
3) Meet the sepsis criteria of SEPSIS-3.
4) Written consent for this study was obtained from the subject or a surrogate.
5) Patients who are expected to survive for 2 weeks.

Appendix: SEPSIS3 Sepsis Criteria
Suspected infection and an increase in total SOFA score of at least 2 points

Exclusion Criteria

1) Patients with a history of hypersensitivity to the study drug
2) Patients with cardiopulmonary arrest at the time of admission
3) Patients who do not wish to undergo active treatment at the time of diagnosis at the request of the patient or family
4) Patients deemed inappropriate for study inclusion by the principal investigator
5) Patients on immunosuppressive drugs
6) Patients using drugs that affect lymphocyte counts

Study & Design

• Study Type: Interventional
• Study Design: Not specified